AXT (AXTI) Shares Climb +50% Over 30 Days on Record Q2 Results and AI Demand
Key Takeaways
- AXT shares climbed roughly 50% over the last 30 days, from a closing price of $48.83 on July 20 to $73.43 on August 19, 2026.
- The rally was driven primarily by record second-quarter results reported on July 30, including revenue up 164% year over year and a return to profitability.
- Record indium phosphide demand tied to AI data-center optical connectivity, plus a new long-term Lumentum supply agreement, reinforced the move.
- Despite the 30-day surge, shares remain well below the late-May peak near $141 following a sharp drawdown earlier in the quarter.
- Export-permit timing and an elevated valuation are the key risks investors are now weighing.
AXT (AXTI) Company Overview and Market Position
AXT, Inc. is a Fremont, California-based materials science company that designs, develops, manufactures, and distributes compound and single-element semiconductor substrates — wafers used where standard silicon cannot meet performance requirements. Its core products include indium phosphide (InP), gallium arsenide (GaAs), and germanium (Ge) substrates. Indium phosphide is especially critical for the optical transceivers and silicon-photonics components used in AI data-center connectivity, a market that has become AXT's primary growth engine. Manufacturing is largely carried out through its Chinese subsidiary, Tongmei, across three facilities in Beijing, with sales, administration, and customer service based in Fremont. AXT's vertically integrated supply chain and proprietary crystal-growth technology are key competitive strengths. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
AXT (AXTI) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, AXT shares rose about 50%, from a closing price of $48.83 on July 20 to $73.43 on August 19. The advance was not linear: shares spiked immediately after the July 30 earnings report and pushed toward a mid-August high above $95 before pulling back.
The last quarter tells a different story. Over the trailing three-month period, the stock is still down roughly 35% from about $113 per share in mid-May. After peaking near $141 on May 22, shares sold off sharply to a late-July trough near $37 on July 29 before the earnings-driven rebound. In other words, the 30-day gain represents a recovery from a deeply oversold base rather than a fresh record high. One thing that stands out here is how quickly sentiment shifted with the fundamentals.
What Drove AXTI Stock Price in the Last 30 Days
The dominant catalyst was AXT's second-quarter 2026 report, released after the market close on July 30. The company posted record revenue of $47.6 million, up 164% year over year, with indium phosphide revenue reaching a record of roughly $30.7 million. Gross margin expanded to about 45% from 8.2% a year earlier, and the company swung to net income of $11.1 million. Non-GAAP earnings per share of $0.19 compared with a consensus estimate near $0.07, and shares jumped more than 50% in after-hours trading.
Forward guidance added further fuel. Management guided third-quarter non-GAAP EPS of $0.30 to $0.32 on revenue of roughly $66 million, a sharp step-up from prior expectations. AXT also announced a long-term indium phosphide supply and capacity-reservation agreement with Lumentum (LITE) supported by $87.5 million in deposits applied as shipment credits through 2031, and disclosed an indium phosphide backlog above $100 million. Several analysts raised targets after the report, with published price targets ranging from $55 to $125. I’m watching this closely because the backlog visibility is unusual for the sector.
What Drove AXT Stock Performance Over the Last Quarter
AXT's quarterly trajectory has been exceptionally volatile. In May, the stock reached roughly $141 as investors bid up the AI-optical-connectivity theme, driving the shares to extreme gains for the year. The subsequent selloff reflected valuation concerns — with the stock trading at a price-to-sales multiple far above historical norms — along with profit-taking and renewed focus on execution risk, particularly the timing of Chinese export permits for indium phosphide shipments and U.S. tariff exposure. The July 30 earnings report reversed the downtrend by showing fundamentals catching up to the AI narrative, but shares remain below the May peak as investors weigh whether the growth is sustainable.
AXTI Stock Forecast Drivers: What Investors Should Watch Next
- Q3 2026 results: AXT's next earnings report is expected around late October 2026, when investors will assess whether the company met its $66 million revenue and $0.30–$0.32 EPS guidance.
- Export permits: The timing of Chinese export approvals for indium phosphide remains a key swing factor for shipments and revenue recognition.
- Capacity ramp: Progress toward doubling indium phosphide capacity in 2026 and again in 2027 will determine whether strong demand can be converted into sales.
- Valuation: With shares trading at a premium price-to-sales multiple, any cooling in AI-optical demand or softer guidance could trigger repricing.
- Customer concentration: Long-term agreements such as the Lumentum deal reduce some risk, but a concentrated customer base and China tariff exposure remain watch items.
Exploring AI-Driven Trading Approaches
Tickeron operates hundreds of AI-powered trading bots that collectively trade thousands of tickers, but only the top-performing and most relevant strategies are featured in its curated Trending AI Robots section. The bots vary widely in strategy, holding timeframe, and performance metrics, giving traders a way to compare automated approaches side by side. For investors watching high-volatility semiconductor names like AXTI, this section provides a useful starting point for exploring how AI-driven strategies are currently positioned across the market.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
AXTI's RSI Indicator peaks and leaves overbought zone
The 10-day RSI Oscillator for AXTI moved out of overbought territory on August 18, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 instances where the indicator moved out of the overbought zone. In 32 of the 36 cases the stock moved lower in the days that followed. This puts the odds of a move down at 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 57 of 65 cases where AXTI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for AXTI entered a downward trend on September 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on AXTI as a result. In 67 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for AXTI just turned positive on September 17, 2026. Looking at past instances where AXTI's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
AXTI moved above its 50-day moving average on September 16, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AXTI crossed bullishly above the 50-day moving average on September 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +8.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in 222 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock slightly worse than average.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.198) is normal, around the industry mean (7.599). AXTI's P/E Ratio (2334.333) is considerably higher than the industry average of (153.531). AXTI's Projected Growth (PEG Ratio) (0.100) is slightly lower than the industry average of (0.796). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (26.596) is also within normal values, averaging (27.897).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufactures of high-performance compound semiconductor substrates
Industry ElectronicProductionEquipment
Advertisement